KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck

Conclusions: These results indicate that KDM5B is a valuable biomarker that can be used to predict SCCHN patient outcome.

Source: Journal of Cancer - June 20, 2018 Category: Cancer & Oncology Authors: Donghai Huang, Yuanzheng Qiu, Guo Li, Chao Liu, Li She, Diekuo Zhang, Xiyu Chen, Gangcai Zhu, Xin Zhang, Yongquan Tian, Yong Liu Tags: Research Paper Source Type: research